Skip to content
← Holders

Ishara Investments LP

What Ishara Investments LP reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2111609 · Filed Nov 16, 2026

Positions
41
Reported value
$121M
Opened
17
Closed
17
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Dec 31, 2025$87.5M
    38 positions
  2. Mar 31, 2026$105.6M
    37 positions
  3. Jun 30, 2026$136.1M
    41 positions
  4. Sep 30, 2026$121M
    41 positions
SecuritySharesChangeValueOf portfolio
TVTXTravere Therapeutics, Inc.
145K+76.8%$8.5M7.1%
CYTKCytokinetics Inc
128K+290.2%$8.4M7%
BBIOBridgeBio Pharma, Inc.
100K+74.2%$6.6M5.4%
ACADAcadia Pharmaceuticals Inc
320K−22.0%$6.4M5.3%
TARSTarsus Pharmaceuticals, Inc.
70KNew$5.5M4.5%
PTCTPTC Therapeutics, Inc.
80KNew$5.2M4.3%
PRAXPraxis Precision Medicines, Inc.
17K−24.6%$5M4.1%
VERAVera Therapeutics, Inc.
150K+1,363.4%$4.8M4%
ARQTArcutis Biotherapeutics, Inc.
180KNew$4.8M3.9%
ANNXAnnexon, Inc.
1.1M+36.6%$4.7M3.9%
UTHRUnited Therapeutics Corp
8KNew$4.3M3.6%
NAMSNewAmsterdam Pharma Co N.V.
160K+333.6%$3.9M3.2%
XERSXeris Biopharma Holdings, Inc.
400K−67.5%$3.8M3.2%
CELCCelcuity Inc.
48KNew$3.8M3.2%
DBVTDBV Technologies S.A.
270K+46.3%$3.2M2.6%
VRDNViridian Therapeutics, Inc.
150KNew$3.1M2.6%
ZNTLZentalis Pharmaceuticals, Inc.
1.1M+5.4%$3M2.5%
BMRNBioMarin Pharmaceutical Inc
48K−66.6%$2.9M2.4%
BIIBBiogen Inc.
12KNew$2.7M2.2%
MLYSMineralys Therapeutics, Inc.
100K−2.4%$2.5M2.1%
LGNDLigand Pharmaceuticals Inc
8KNew$2.5M2.1%
RAREUltragenyx Pharmaceutical Inc.
160K−22.0%$2.4M2%
PCVXVaxcyte, Inc.
40K−51.2%$2.3M1.9%
ORICOric Pharmaceuticals, Inc.
160K+30.1%$2.2M1.8%
AXSMAxsome Therapeutics, Inc.
10K−39.0%$1.8M1.5%
SLNSilence Therapeutics plc
160K+189.1%$1.7M1.4%
BEAMBeam Therapeutics Inc.
70K+70.7%$1.7M1.4%
BHVNBiohaven Ltd.
120KNew$1.6M1.3%
RAREUltragenyx Pharmaceutical Inc.Put option
1KNew$1.5M1.2%
CTNMContineum Therapeutics, Inc.
108K−47.3%$1.4M1.2%
GMABGenmab A/S
40K−61.0%$1.4M1.2%
NBIXNeurocrine Biosciences Inc
8KNew$1.1M0.9%
MNPRMonopar Therapeutics
12K−2.4%$956K0.8%
MLTXMoonLake Immunotherapeutics
80KNew$936K0.8%
SPRYARS Pharmaceuticals, Inc.
200K+39.4%$862K0.7%
IONSIonis Pharmaceuticals Inc
16KNew$714.4K0.6%
OLMAOlema Oncology, Inc.
80KNew$691.2K0.6%
LXRXLexicon Pharmaceuticals, Inc.
320K−74.8%$600K0.5%
WVEWave Life Sciences, Inc.
160KNew$592K0.5%
SVRASavara Inc
80KNew$412.8K0.3%
GOSSGossamer Bio, Inc.
24KNew$284.4K0.2%